Literature DB >> 33765344

An overview of traditional Chinese medicine therapy for Helicobacter pylori-related gastritis.

Yuli Li1, Xiaoya Li1, Zhoujin Tan1.   

Abstract

BACKGROUND: Helicobacter pylori-associated gastritis (HPAG) is a common digestive system disease that its therapeutic goal is to eradicate Helicobacter pylori. However, due to the widespread use of antibiotics, problems for example, antibiotic resistance, reinfection, and gastrointestinal side effects have emerged. The solution of above problems provides a broad space for traditional Chinese medicine (TCM) to exert its remarkable advantages on the treatment of HPAG.
METHODS: Extensive database retrieval using platforms not limited to but including Web of Science, SpringerLink, ScienceDirect, Google Scholar, China National Knowledge Infrastructure, Wanfang, and VIP database was performed using keywords such as "Helicobacter pylori-associated gastritis" or "HPAG" or "Helicobacter pylori" or "H. pylori" or "gastritis" and "traditional Chinese medicine" or "TCM" or "herbs" or "Chinese herbal medicine". In addition, related books, PhD, and master's dissertations were also researched to provide a comprehensive review.
RESULTS: This review mainly introduces the clinical efficacy of TCM formulas for HPAG, as well as active ingredient and pharmacological mechanisms of herbs. What's more, this review puts forward potential prospects for future research.
CONCLUSION: These research works have shown the therapeutic benefits of TCM in the treatment of HPAG. The development of TCM with more specific functions and practical data will not only become a significant trend in the world market but also have an irreplaceable role in the future treatment of HPAG. More continued researches should be undertaken in the future.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990Helicobacter pylorizzm321990; Helicobacter pylori-associated gastritis; pathogenesis; traditional Chinese medicine

Year:  2021        PMID: 33765344     DOI: 10.1111/hel.12799

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  6 in total

1.  TCMPG: an integrative database for traditional Chinese medicine plant genomes.

Authors:  Fanbo Meng; Qiang Tang; Tianzhe Chu; Xianhai Li; Yue Lin; Xiaoming Song; Wei Chen
Journal:  Hortic Res       Date:  2022-03-08       Impact factor: 7.291

2.  Gastrointestinal microbiome and Helicobacter pylori: Eradicate, leave it as it is, or take a personalized benefit-risk approach?

Authors:  Stanislav Sitkin; Leonid Lazebnik; Elena Avalueva; Svetlana Kononova; Timur Vakhitov
Journal:  World J Gastroenterol       Date:  2022-02-21       Impact factor: 5.742

3.  Saccharomyces boulardii Allows Partial Patients to Avoid Reusing Bismuth Quadruple for Helicobacter pylori Rescue Therapy: A Single-Center Randomized Controlled Study.

Authors:  Peng Qu; Xiaoming Liu; Xiujuan Xia; Xiaoran Xie; Ju Luo; Sha Cheng; Jingshu Chi; Peng Liu; Huan Li; Wenfang Zhao; Huihao Yang; Canxia Xu
Journal:  Front Cell Infect Microbiol       Date:  2022-07-08       Impact factor: 6.073

4.  Evaluation of Susceptibility of the Human Pathogen Helicobacter pylori to the Antibiotic Capreomycin.

Authors:  Suriyan Sukati; Imran Sama-Ae; Gerd Katzenmeier; Sueptrakool Wisessombat
Journal:  ScientificWorldJournal       Date:  2022-07-31

Review 5.  The Origin and Development of Piji Pills: An Ancient Prescription of Traditional Chinese Medicine.

Authors:  Fudong Liu; Xiaochen Jiang; Chuanlong Zhang; Guibin Wang; Yi Li; Bo Pang
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-12       Impact factor: 2.650

6.  Jinghua Weikang capsule for helicobacter pylori eradication: A systematic review and meta-analysis with trial sequential analysis.

Authors:  Qian Zhao; Wen-Jia Wang; Shui-Ping Zhou; Jing Su; He Sun; Jing-Bo Zhai; Yun-Hui Hu
Journal:  Front Pharmacol       Date:  2022-09-26       Impact factor: 5.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.